Diane K. Wherrett

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Kevan C. Herold, Brian N. Bundy, S. Alice Long et al. · New England Journal of Medicine · 2019 · 1.1K citations · Full text

Medicine, Immunology, Internal Medicine +17

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

Life Sciences, Endocrinology, Immunology +16

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

Tihamer Orban, Brian N. Bundy, Dorothy J. Becker et al. · The Lancet · 2011 · 601 citations

Medicine, Endocrinology, Pharmacotherapy +9

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

Diane K. Wherrett, Brian N. Bundy, Dorothy J. Becker et al. · The Lancet · 2011 · 369 citations

Veterinary Medicine, Immunology, Immunization +12

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Emily K. Sims, Brian N. Bundy, Kenneth Stier et al. · Science Translational Medicine · 2021 · 359 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17